2-Butenoic acid,[(3R,4R,5R)-3,4,5-trihydroxy-6-oxo-1-cyclohexen-1-yl]methyl ester, (2E)- (62532-49-4)

Identification
Name:	2-Butenoic acid,[(3R,4R,5R)-3,4,5-trihydroxy-6-oxo-1-cyclohexen-1-yl]methyl ester, (2E)-
Synonyms:	2-Butenoicacid, (3,4,5-trihydroxy-6-oxo-1-cyclohexen-1-yl)methyl ester, [3R-[1(E),3a,4a,5a]]-; 2-Crotonyloxymethyl-(4R,5R,6R)-4,5,6-trihydroxycyclohex-2-enone; COTC
CAS:	62532-49-4
Molecular Formula:	C11H14 O6
Molecular Weight:	0
InChI:	InChI=1/C11H14O6/c1-2-3-8(13)17-5-6-4-7(12)10(15)11(16)9(6)14/h2-4,7,10-12,15-16H,5H2,1H3/b3-2+/t7-,10-,11+/m1/s1
Molecular Structure:
Properties
Flash Point:	163.3°C
Boiling Point:	420.3°C at 760 mmHg
Density:	1.43g/cm³
Refractive index:	1.59
Flash Point:	163.3°C
Safety Data

Other Product

Cyclohexanecarboxylicacid, 1,3,4-trihydroxy-5-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-,(1S,3R,4R,5R)-
Cyclohexanecarboxylic acid,3-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-,butyl ester, (1S,3R,4R,5R)-
2-Butenoic acid, 4-(2-hydroxy-6-oxo-1-cyclohexen-1-yl)-, ethyl ester, (2E)- (9CI)
2-Butenoic acid, 3-(2-methyl-3-oxo-1-cyclohexen-1-yl)-, ethyl ester,(2E)-
3-[[4-[2-[1-[(2S,3R,4R,5R)-6-carboxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]tetrazol-5-yl]phenyl]phenyl]methyl]-2-ethoxy-benzimidazole-4-carboxylic acid
Cyclohexanecarboxylic acid,3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-,methyl ester, (1S,3R,4R,5R)-
(3R,4R,5R,6S)-3,4,5-trihydroxy-6-[2-(2-methyl-5-nitro-imidazol-1-yl)ethoxy]tetrahydropyran-2-carboxylic acid
Cyclohexanecarboxylic acid,1,3,4-trihydroxy-5-[[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]oxy]-, (1R,3R,4S,5R)-
2-Butenoic acid, 2-chloro-5,5-dimethyl-3-oxo-1-cyclohexen-1-yl ester,(2E)-
N-[(2R,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-1-oxo-2-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
N-[(2R,3R,4R,5R)-3,5,6-trihydroxy-1-oxo-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hexan-2-yl]acetamide
Cyclohexanecarboxylic acid,1,3,4-trihydroxy-5-[[3-(4-hydroxy-3,6-dioxo-1,4-cyclohexadien-1-yl)-1-oxo-2-propenyl]oxy]-, (1S,3R,4R,5R)-
2H-Pyran-2-acetamide,N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-5-[(1E,3E,5E)-7-(1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-pyridinyl)-6-methyl-7-oxo-1,3,5-heptatrien-1-yl]tetrahydro-3,4-dihydroxy-2-furanyl]-6-methoxy-5-methyl-2,4-octadien-1-yl]-a-ethyltetrahydro-2,3,4-trihydroxy-5,5-dimethyl-6-(1E,3Z)-1,3-pentadien-1-yl-,(aS,2R,3R,4R,6S)-
2-Butenoic acid,2-methyl-,(4S,4aS,5R,6S,- 8aR,9aR)-2,4,4a,5,6,7,8,8a,9,9a-decahydro-3,- 4a,5-trimethyl-6-[[(2E)-3-[(S)-methylsulfinyl]- 1-oxo-2-propenyl]oxy]-2- oxonaphtho[2,3-b]furan-4-yl ester,(2Z)-
2-Butenoic acid,4-[(2S,3S,5S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]tetrahydro-5-[(2E,4R,5S)-4-methyl-5-[(triethylsilyl)oxy]-2-hexen-1-yl]-4-oxo-2H-pyran-2-yl]-3-methyl-, methyl ester, (2E)-
2-Butenoic acid, 2-methyl-,(1R,3R,5R)-6-hydroxy-8-azabicyclo[3.2.1]oct-3-yl ester, (2E)-rel-
sodium; 4-[5,7-dihydroxy-4-oxo-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxymethyl]oxan-2-yl]oxy-chromen-2-yl]-2-hydroxy-phenolate; sulfuric acid
(2S,3S,4R,5R,6R)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}
2-Butenoic acid,3-[(1R)-4-methyl-3-cyclohexen-1-yl]-, (2E)-
Cyclohexanecarboxylic acid,1,3,4-trihydroxy-5-[[1-oxo-3-(2,4,5-trihydroxyphenyl)-2-propenyl]oxy]-,(1S,3R,4R,5R)-